Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Obstetrics and Gynecology

Volume  5, Issue 1, January - March 2017, Pages 13-18
 

Original Article

Local Ultrasound Guided Intra-Embryonic KCL Instillation with Systemic Methotrexate Versus Methotrexate Alone in Management of Live Tubal Ectopic Pregnancy: A Case Series

Nutan Agarwal*, Vidushi Kulshrestha**, Alka Kriplani*, Neerja Bhatla*

*Professor **Assistant Professor, Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi – 110029.

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/ijog.2321.1636.5117.1

Abstract

 Objective: To compare efficacy of systemic methotrexate with concurrent intra-embryonic potassium chloride (KCl) instillation versus systemic methotrexate alone in cases of live unruptured ectopic pregnancies. Method: In this retrospective comparative study conducted in tertiary care centre; six patients with documented cardiac activity suitable for medical management were given ultrasound-guided intra-embryonic KCl along with systemic methotrexate (Mtx) (Group-1). Their response was compared with six historical cases managed with systemic Mtx alone (Group-2). Results: Medical management was successful in 100% patients in Group-1 treated with combined KCl and Mtx, all responded to only single dose of Mtx. In Group-2, success rate was 83% where 2/6(33.3%) cases were successfully treated with single dose; 3/6(50%) patients responded to 2nd dose of Mtx and 1/6(16.7%) case had rupture. Mean duration for hCG to become negative was 5 weeks (range 3-7 weeks) in Group-1 versus 7.2 weeks (range 4-10 weeks) in Group-2. Conclusion: Live unruptured tubal ectopic pregnancies can be effectively managed with intraembryonic KCl and concurrent systemic Mtx therapy. Addition of KCl alleviates the need for second Mtx dose, minimizes the risk of rupture and results in faster fall of hCG. Patients with high baseline hCG can also be effectively treated with this combined treatment.

Keywords: Live Ectopic Pregnancy; Medical Management; Methotrexate; KCl Injection. Synopsis: Ultrasound-guided intraembryonic KCl instillation with systemic methotrexate may alleviate need for second Mtx dose, minimize risk of rupture and reduce follow-up with serial âhCG.


Corresponding Author : Nutan Agarwal*